41 results about "Molecular Transport" patented technology

Provided herein composition and methods for nanoporous membranes comprising single walled, double walled, or multi-walled carbon nanotubes embedded in a matrix material. Average pore size of the carbon nanotube can be 6 nm or less. These membranes are a robust platform for the study of confined molecular transport, with applications in liquid and gas separations and chemical sensing including desalination, dialysis, and fabric formation.

Preparations of novel molecular transporter compositions and their use for transporting bioactive substances into cells in living animals are disclosed. To afford in vivo delivery, the composition is covalently linked to the bioactive substance and the resultant composite structure is introduced into the subject. The transporter composition includes multiple guanidine moieties on a dendrimeric scaffold having a triazine core.

A nanoengineered membrane for controlling material transport (e.g., molecular transport) is disclosed. The membrane includes a substrate, a cover defining a material transport channel between the substrate and the cover, and a plurality of fibers positioned in the channel and connected to and extending away from a surface of the substrate. The fibers are aligned perpendicular to the surface of the substrate, and have a width of 100 nanometers or less. The diffusion limits for material transport are controlled by the separation of the fibers. In one embodiment, chemical derivatization of carbon fibers may be undertaken to further affect the diffusion limits or affect selective permeability or facilitated transport. For example, a coating can be applied to at least a portion of the fibers. In another embodiment, individually addressable carbon nanofibers can be integrated with the membrane to provide an electrical driving force for material transport.

The invention relates to transport systems for molecular substances, comprising a mosaic of recombinant partial units (individual components). The invention further relates to production of the molecular transport system and use thereof.

The invention discloses a method for designing and controlling the microstructure of an explosive based on supramolecular assembly and disassembly. The method comprises the following steps of: forming an energetic supramolecular cocrystal system through supramolecular self-assembly with energetic materials as host molecules and guest molecules; disassembling the guest molecules in the supramolecular cocrystal system under the action of an external force to obtain an energetic material with a special microstructure; and completing the design and control of the explosive microstructure. The method provided by the invention can design the microstructure of the energetic material from a molecular level, thereby realizing the controllable molecular transport and operation of the energetic material supramolecular system. The control of the inter-molecule action force from a micro level has influence on the change of a larger microstructure. The detonation performance and combustion performance of the obtained energetic material with the special microstructure are improved.

By adding the novel developed modular antigen transporter molecules (MAT molecules) and other instruments related thereto, the immune system of an individual can be effectively modulated in a targetedmanner. The MAT molecules contain a translocation module which transports the MAT molecule inside the cell, an active intracellular targeting molecule resulting in intracellular transport of the MATmolecule to the organelles of the cell which are responsible for antigen processing and an antigen module which determines the specificity of the immune response modulated by the MAT molecule. Optionally, other modules such as tag modules or spacer modules can be contained in the MAT molecule. The invention comprises the inventive MAT molecules, antibodies which are produced using said MAT molecules and therapeutic agents and diagnostic reagents which are produced with MAT molecules. The invention also comprises applications containing said MAT molecules, antibodies, therapeutic agents and diagnostic reagents.

Disclosed herein is a composition comprising a nanochannel and a contained substance, wherein the nanochannel comprises a single-file nanochannel and the contained substance comprises a plurality of substance particles arranged in a single-file chain within the nanochannel. Methods and systems for molecular transport of a substance through a nanochannel are also provided that rely upon the use of nanojumps, where nanojumps mediate the transport through the nanochannel.

The invention relates to a sodium alginate-flaky ZIF-8 hybrid composite membrane, and belongs to the field of membrane separation. At first, Zn(NO3)2 and 2-methylimidazole are used as raw materials, and flaky ZIF-8 is prepared in a water phase form through control of synthesis conditions; then, the prepared platy ZIF-8 is dispersed in a sodium alginate water solution to prepare a casting solution, after standing and defoaming, the casting solution spirally coats the surface of a porous polymer ultrafiltration membrane, after drying, the porous polymer ultrafiltration membrane is crosslinked with a calcium chloride solution, and after drying again, the sodium alginate- flaky ZIF-8 hybrid composite membrane is obtained. The hybrid composite membrane can be used for dehydration through pervaporation of an ethanol / water system. Through utilization of the second-dimensional structure and the porous structure of the flaky ZIF-8, the screening effect of the hybrid composite membrane on molecular transport is enhanced, so that the separation performance of the hybrid composite membrane is improved. The preparation process is simple, raw materials are easy to obtain, the structure is controllable, the large-scale preparation and amplification are convenient, and the sodium alginate-flaky ZIF-8 hybrid composite membrane has a good application prospect.

The present invention provides conjugates, processes for their preparation, and the use of these conjugates for transporting low-molecular-weight compounds and macromolecules across biological membranes, in particular for transporting molecules into cells. The present invention also provides pharmaceutical compositions, diagnostic aids, and test kits in which these conjugates are present or used.

The inventive molecular transporter compound shows significantly high permeability through a biological membrane such as a plasma membrane, nuclear membrane and blood-brain barrier, and accordingly, can be effectively used in delivering various biologically active molecules.

An oligo-guanidine as cell penetrating agents / carriers includes a heterocyclic ring including 4-aminopiperidine, piperazine, morpholine having at least one N-terminal based heterocyclic ring or at least one O-heteroatom based heterocyclic ring tailored with hydrophobic and / or lipophilic group. The oligo-guanidine is adapted as an effective molecular transporter to transport and / or delivery therapeutics, therapeutic candidates, probes, or other molecules of interest across biological barriers including oligonucleotides. Advantageously, the oligo-guanidine is capable of being internalized into cells (in-vitro and in-vivo) with enhanced cellular uptake in nanomolar concentration.

An oligo-guanidine as cell penetrating agents / carriers includes a heterocyclic ring including 4-aminopiperidine, piperazine, morpholine having at least one N-terminal based heterocyclic ring or at least one O-heteroatom based heterocyclic ring tailored with hydrophobic and / or lipophilic group. The oligo-guanidine is adapted as an effective molecular transporter to transport and / or delivery therapeutics, therapeutic candidates, probes, or other molecules of interest across biological barriers including oligonucleotides. Advantageously, the oligo-guanidine is capable of being internalized into cells (in-vitro and in-vivo) with enhanced cellular uptake in nanomolar concentration.